THE NATIONAL ACADEMIES OF SCIENCES, ENGINEERING, AND MEDICINE
Policy and Global Affairs
Committee on Women in Science, Engineering, and Medicine
Committee on Improving the Representation of Women and Underrepresented Minorities
in Clinical Trials and Research
*****
Congressional Briefing
Monday, May 16, 2022 – 2:30 p.m.
via Zoom
on
Improving Representation in Clinical Trials and Research
Building Research Equity for Women and Underrepresented Groups
Requested by Congress in P.L. 116- 94, the Further Consolidated Appropriations Act, 2020, this new report from the National Academies of Sciences, Engineering, and Medicine identifies policies, procedures, programs, or projects aimed at increasing the inclusion of these groups in clinical research and the specific strategies used by those conducting clinical trials and clinical and translational research to improve diversity and inclusion. This report models the potential economic benefits of full inclusion of men, women, and racial and ethnic groups in clinical research and highlights new programs and interventions in medical centers and other clinical settings designed to increase participation.
This briefing was for members of Congress and congressional staff only. The report was publicly released on May 17, 2022 and can be found, in its entirety, on the Web site of the National Academies Press.